| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
| ln Vitro |
HET0016 inhibits CYP4A in a selective, non-competitive, and irreversible manner [1]. Breast cancer metastatic cells are less likely to migrate and invade when exposed to HET0016 (100 μM) for 24 or 48 hours [2].
|
|---|---|
| ln Vivo |
In an immunocompetent mouse model of breast cancer, HET0016 (10 mg/kg/day; intravenously; for 3 weeks) decreases tumor volume and lung metastases [2]. By inhibiting the PI3K/AKT pathway, HET0016 lowers the amounts of metalloproteinases in the lungs of mice [2]. In the lung microenvironment, HET0016 decreases the expression of growth factors, pro-inflammatory factors, and granulocyte MDSC populations [2]. By controlling the expression of tight junction proteins and MMP-9, HET0016 prevents BBB dysfunction following I/R [3].
|
| Cell Assay |
Cell proliferation assay[2]
Cell Types: MDA-MB-231 Cell Tested Concentrations: 100 μM Incubation Duration: 24 hrs (hours), 48 hrs (hours) Experimental Results: diminished migration and invasion of breast cancer metastatic cells |
| Animal Protocol |
Animal/Disease Models: 4-5 weeks female balb/c (Bagg ALBino) mouse (16-18 g) [2]
Doses: 10 mg/kg/day Route of Administration: intravenous (iv) (iv)injection; 5 days per week; for 3 weeks; from tumor implantation Results started on day 15: reduction in tumor volume and lung metastases. |
| References |
|
| Additional Infomation |
HET0016 is a member of toluenes.
|
| Molecular Formula |
C₁₂H₁₈N₂O
|
|---|---|
| Molecular Weight |
206.28
|
| Exact Mass |
206.141
|
| CAS # |
339068-25-6
|
| PubChem CID |
2727594
|
| Appearance |
White to off-white solid powder
|
| Density |
1.0±0.1 g/cm3
|
| Boiling Point |
356.9±52.0 °C at 760 mmHg
|
| Flash Point |
169.7±30.7 °C
|
| Vapour Pressure |
0.0±0.8 mmHg at 25°C
|
| Index of Refraction |
1.524
|
| LogP |
4.13
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
15
|
| Complexity |
194
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
LYNOGBKNFIHKLE-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C12H18N2O/c1-3-4-5-11-6-7-12(10(2)8-11)13-9-14-15/h6-9,15H,3-5H2,1-2H3,(H,13,14)
|
| Chemical Name |
N'-(4-butyl-2-methylphenyl)-N-hydroxymethanimidamide
|
| Synonyms |
HET0016; HET-0016
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DCM : 12.5 mg/mL (~60.60 mM)
DMSO : ~5 mg/mL (~24.24 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 2 mg/mL (9.70 mM) in 20% HP-β-CD in Saline (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.8478 mL | 24.2389 mL | 48.4778 mL | |
| 5 mM | 0.9696 mL | 4.8478 mL | 9.6956 mL | |
| 10 mM | 0.4848 mL | 2.4239 mL | 4.8478 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
